SymphonyAI

SymphonyAI is a leading enterprise AI SaaS company, headquartered in Palo Alto, California, with a global workforce of 2,500 professionals across 26 countries. It specializes in productized, packaged AI application suites for high-value use cases in key verticals, including retail/CPG, financial services, industrial, enterprise IT, and media. The company's innovative offerings are built on the EurekaAI platform, which leverages predictive, generative, and agentic AI. SymphonyAI's software applications empower over 2,000 global organizations by unlocking insights and addressing business challenges. Notably, Symphony MediaAI, a subsidiary focused on the media and entertainment sector, provides revenue optimization solutions through its Revedia platform, helping media companies manage licensing agreements and normalize data from various platforms.

11 past transactions

Ansel

Venture Round in 2024
Ansel Health is a developer of a health insurance platform designed for employers to improve employee benefits through a straightforward supplemental health benefits plan. The company provides insurance services that offer cash payouts to individuals diagnosed with various conditions, including those related to COVID-19. This support helps alleviate financial burdens associated with serious health issues, ensuring that employees have access to necessary resources for recovery.

1010data

Acquisition in 2023
1010data, Inc. specializes in big data discovery and data sharing solutions designed for both business and technical users. The company offers a range of products, including its Big Data Discovery platform, which allows users to analyze data where it is stored, and Advanced Analytics tools that encompass statistics, predictive modeling, and machine learning. Other offerings include Data Sharing and Monetization solutions for organizations to collaborate with partners, as well as industry-specific applications that integrate enterprise and third-party data for strategic insights. The cloud-based Analytical Platform as a Service (APaaS) provides a comprehensive suite of capabilities, including an analytical database, user-friendly interfaces, and data integration features. 1010data serves a diverse clientele across various sectors, such as retail, financial services, healthcare, and government, helping them to enhance performance and adapt to changes in the market. Headquartered in New York, the company has been operational since 1999 and has established itself as a trusted partner for leading organizations seeking to leverage data for improved decision-making and operational efficiency.

SymphonyAI Sensa-NetReveal

Acquisition in 2022
SymphonyAI Sensa-NetReveal specializes in risk management and fraud detection, focusing on regulatory compliance and the prevention of financial crime. The company collaborates with financial institutions worldwide to optimize risk management operations through advanced data management and analytical capabilities. Its services include investigation management, workflow, and reporting, which are designed to combat financial crime, fraud, and cyber attacks in the banking, financial, and insurance sectors. By leveraging digital and AI technologies, SymphonyAI Sensa-NetReveal aims to enhance the effectiveness of its clients' risk management strategies and contribute to a more secure financial environment.

Ansel

Series A in 2021
Ansel Health is a developer of a health insurance platform designed for employers to improve employee benefits through a straightforward supplemental health benefits plan. The company provides insurance services that offer cash payouts to individuals diagnosed with various conditions, including those related to COVID-19. This support helps alleviate financial burdens associated with serious health issues, ensuring that employees have access to necessary resources for recovery.

Ansel

Seed Round in 2020
Ansel Health is a developer of a health insurance platform designed for employers to improve employee benefits through a straightforward supplemental health benefits plan. The company provides insurance services that offer cash payouts to individuals diagnosed with various conditions, including those related to COVID-19. This support helps alleviate financial burdens associated with serious health issues, ensuring that employees have access to necessary resources for recovery.

Ansel

Seed Round in 2020
Ansel Health is a developer of a health insurance platform designed for employers to improve employee benefits through a straightforward supplemental health benefits plan. The company provides insurance services that offer cash payouts to individuals diagnosed with various conditions, including those related to COVID-19. This support helps alleviate financial burdens associated with serious health issues, ensuring that employees have access to necessary resources for recovery.

TeraRecon

Acquisition in 2020
TeraRecon, Inc. is a prominent provider of enterprise medical image management and visualization solutions for healthcare organizations globally. Established in 1997 and headquartered in Durham, North Carolina, with additional offices in Japan, Germany, Massachusetts, and Brazil, TeraRecon specializes in advanced imaging technologies that enhance image processing and 3D visualization capabilities. The company offers a diverse range of products, including its flagship solution, iNtuition, which supports neuroimaging, oncology, volumetric cardiac imaging, and vascular planning. Other notable offerings include iNtuitionREVIEW, AI Sync technology, iNtuitionCLOUD, and iNtuitionEMV, which facilitate seamless integration and sharing of medical images and data. TeraRecon is recognized for its innovative advancements in medical imaging, having received multiple awards for its contributions to the field, and continues to focus on improving clinical care through its cutting-edge technologies and training services.

ConcertAI

Series B in 2020
ConcertAI is a Boston-based company established in 2018 that specializes in developing a suite of medical research tools focused on oncology. The company aims to enhance care-based oncology research and data analytics through its integrated real-world data and AI-driven solutions. ConcertAI’s offerings are designed to improve oncology health outcomes and clinical trial efficiency by utilizing custom patient surveys. This enables pharmaceutical companies to assess existing treatments and advance the development of new therapies. By facilitating the generation of real-world evidence and insights, ConcertAI assists project teams, medical experts, and scientists in delivering impactful research and innovations in cancer care.

Azima

Acquisition in 2019
Azima is an information services and analytics company, that provides Web-based and wireless monitoring and diagnostic services for industrial equipment.

SymphonyAI Sensa

Acquisition in 2019
SymphonyAI Sensa specializes in advanced crime detection services tailored for financial institutions globally. Utilizing a unique blend of artificial intelligence and machine learning, Sensa identifies criminal activities that traditional detection systems often overlook. Customers have reported significant improvements, including an 81-fold enhancement in risk-to-alert ratios, a 263% increase in Suspicious Activity Reports (SARs), and a 77% reduction in false positives. The platform not only provides predictive insights but also streamlines operations by accurately pinpointing genuine anomalies within existing data. Sensa is designed to be user-friendly and offers fully explainable results, ensuring compliance with regulatory standards.

Precision Health AI

Series A in 2017
Precision Health AI is a platform technology company focused on applications of AI to Oncology. Serving Pharma, Life Sciences, Providers, and Payers PH.AI combines modern AI technology with best in class oncology data with a focus on improving outcomes and driving value based care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.